ACLX FY 2025 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M-79.4% YoY

Gross Profit

$16M70.0% margin

Operating Income

-$253M-1135.6% margin

Net Income

-$229M-1027.3% margin

EPS (Diluted)

$-4.07

Cash Flow

Operating Cash Flow

-$210M

Free Cash Flow

-$213M

Stock-Based Comp.

$78M

Balance Sheet

Total Assets

$604M

Total Liabilities

$202M

Stockholders' Equity

$402M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$108M	-79.4%
Gross Profit	$16M	$103M	-84.8%
Operating Income	-$253M	-$138M	-84.0%
Net Income	-$229M	-$107M	-113.3%